Insider trade

Becton Dickinson (BDX): CEO exercised options on 43K units

Thomas E Jr Polen, CEO at Becton Dickinson, reported an option exercise of 43K units.

43K
Derivative units
Traded
Aug 13, 2026
Filed
Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
  2. May 21, 2026CongressDisclosed sale of BDX — reported range $1,001 - $15,000
  3. Jun 24, 2026InsiderOfficer sold ~$160K of BDX shares in the open market
  4. Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: SureStep Intermittent Catheter Tray REF: INTP16 INTS14 INTS14C INTS16 INTS16C PEDINTS06 PEDINTS08 PEDINTS10 UDI code:…
  5. Jun 26, 2026InsiderOfficer sold ~$11K of BDX shares in the open market
  6. Jul 9, 2026FDARecall: BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol), 60 x 1 mL applicators/carton, 0.03fl oz (1 mL) each, STERILE SOLUTIO…
  7. Jul 10, 2026FDAFDA device clearance: Minnesota Four-Lumen Esophagogastric Tamponade Tube - 18 French (0092220); Blakemore Esophageal-Nasogastric Tube - 20 French (0092100); Blakemore Esophageal-Na…
  8. Jul 19, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On July 19, 2026, Michael D. Garrison, Executive Vice President and President of the Medical Essentials and BioPharma Systems segments of Becton, Dickinson and Company (“BD”), informed BD of his intention to retire.”
  9. Jul 27, 2026InsiderOfficer sold ~$12K of BDX shares in the open market
  10. Jul 30, 2026FDARecall: BD Needle Kit for Powered Driver 15mm x 15Ga, REF: D015151NK, BD Needle Kit for Powered Driver 25mm x 15Ga, REF: D015251NK, BD Needle Kit for Powered Driver 35…
  11. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
  12. Aug 6, 20265% stakeFirst Eagle Investment Management, LLC reported a passive stake (13G) of 5.1%
  13. Aug 7, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.4%
  14. Aug 10, 2026FDARecall: Power-Trialysis Short-Term Straight Dialysis Catheter, REF: 5605150; Power-Trialysis Short-Term Straight Dialysis Catheter, REF: 5605200; Power-Trialysis Short…
  15. Aug 10, 2026FDARecall: DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625150; DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625200; DuoGlide Short-Term Straight Dialys…
  16. Aug 11, 2026FDARecall: ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI code: 00690103210927 The non-invasive ForeSight oximeter cable is intended for use as an adjunct moni…
  17. Aug 11, 2026InsiderOfficer sold ~$441K of BDX shares in the open market
  18. Aug 13, 2026FDARecall: BD Phoenix Panel NMIC-306. Catalog Number: 449292.
  19. Aug 13, 2026FDARecall: BD Phoenix Panel NMIC-312. Catalog Number: 449082.
  20. Aug 13, 2026InsiderCEO sold ~$768K of BDX shares in the open market

What came next

  1. Aug 14, 2026FDAFDA device clearance: EnCor EnCompass™ Breast Biopsy and Tissue Removal System
  2. Aug 20, 2026FDARecall: EnCor EnCompass Breast Biopsy and Tissue Removal System Console (model number: ENCPCONSOLE) and Driver (model number: ENCPDRIVER) with software
  3. Aug 26, 2026InsiderOfficer sold ~$31K of BDX shares in the open market
  4. Sep 14, 2026FDAFDA device clearance: BD BBL Mueller Hinton II Broth (Cation-Adjusted); BD Difco Mueller Hinton Broth
  5. Sep 24, 2026Layoff notice · 3750 Torrey View Court San Diego CA 92130Layoff notice filed in CA: 85 employees
  6. Sep 25, 2026FDAFDA device approval: Liverty™ TIPS Stent Graft
  7. Sep 28, 2026FDAFDA device clearance: Phasix ST Parastomal Hernia Mesh
  8. Sep 28, 2026InsiderOfficer sold ~$14K of BDX shares in the open market
  9. Oct 16, 2026FDAFDA device clearance: BD Vacutainer® Serum Blood Collection Tubes; BD Vacutainer® Rapid Serum Tubes (RST)
  10. Oct 26, 2026InsiderOfficer sold ~$15K of BDX shares in the open market
  11. Nov 5, 2026Company filing · Form 8-K · ResultsReported its results
  12. Nov 5, 2026InsiderCEO sold ~$629K of BDX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Becton Dickinson

For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.

Other recent filings by Thomas E Jr Polen, Chairman, CEO and President

The full history of Thomas E Jr Polen, Chairman, CEO and President is on the profile page.

How this filing works

Explore the data

Common questions

Which Becton Dickinson (BDX) insider traded, and how much?

Thomas E Jr Polen, CEO at Becton Dickinson, reported an option exercise of 43K units. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Aug 13, 2026. Filed: Aug 14, 2026. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Becton Dickinson recently?

For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BDX page.

Does this mean BDX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Becton Dickinson

Everything OQRO holds on this company is on its BDX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data